China Everbright Limited Information

China Everbright Limited (Everbright, stock code: 165.HK) was established in Hong Kong in 1997 with over 20 years’ experience in PE investments and asset management. It is China’s leading cross-border investment and asset management company, backed by its parent company China Everbright Group. Through the private equity funds, venture capital funds, industry funds, mezzanine funds, fund of funds, fixed income and equity funds it manages, Everbright cultivates a number of high-growth-potential enterprises together with its investors. While closely following the development requirements of Chinese companies, it also introduces the best overseas technologies into the Chinese market, providing multifaceted services to Chinese and overseas clients. Moreover, via its principal investment, Everbright is cultivating CALC, the largest independent aircraft leasing operator in China; incubating CEL Terminus, a unicorn enterprise specialising in AI and Internet of Things; and also integrating high-end elderly care platforms in China to build a proprietary and quality senior care brand. As of 31 December 2018, Everbright managed 62 funds and a total AUM of HK$143.5 billion. Through both proprietary funds and the funds it manages, Everbright has invested in companies both in China and globally, including China UMS, Goldwind, CECEP Wind-power Corporation, HC SemiTek, BGI, Betta Pharmaceuticals Co. Ltd., Amcare, LifeTech Scientific Corporation, Focus Media, iQiYi, SenseTime, NIO, Tirana International Airport, Boreal, Burke Porter Group, Wish, Xjet and Satixfy, etc. It has invested in a total of over 300 companies, covering fields including real estate, aircraft leasing, medical & healthcare, elderly care, new energy, infrastructure, high-level manufacturing, advanced technology and cultural consumption. Of these, more than 150 companies have been listed in China or overseas, or were listed but have since withdrawn due to mergers and acquisitions.